Myriad Genetics Inc
XETRA:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XETRA:MYD
|
US |
|
Learning Technologies Group PLC
LSE:LTG
|
UK |
|
Publity AG
XETRA:PBY
|
DE |
|
Gold Circuit Electronics Ltd
TWSE:2368
|
TW |
|
Timex Group India Ltd
BSE:500414
|
IN |
|
W
|
Wuxi Boton Technology Ltd
SZSE:300031
|
CN |
|
K
|
KME Group SpA
MIL:KME
|
IT |
|
V
|
Visa Inc
XETRA:3V64
|
US |
|
Nanfang Communication Holdings Ltd
HKEX:1617
|
HK |
|
MIT Holdings Co Ltd
TSE:4016
|
JP |
|
Hanon Systems
KRX:018880
|
KR |
|
H
|
Hyundai Corp
KRX:011760
|
KR |
|
Dogus Otomotiv Servis ve Ticaret AS
IST:DOAS.E
|
TR |
|
EMCOR Group Inc
NYSE:EME
|
US |
|
M
|
MAG Holdings Berhad
KLSE:MAGNUM
|
MY |
|
P
|
PENN Entertainment Inc
SWB:PN1
|
US |
|
Power Assets Holdings Ltd
HKEX:6
|
HK |
|
Merit Group PLC
LSE:MRIT
|
UK |
|
T
|
Thang Long Joint Stock Corp
VN:TTL
|
VN |
|
Realord Group Holdings Ltd
HKEX:1196
|
HK |
|
Megastar Foods Ltd
NSE:MEGASTAR
|
IN |
|
Nippon Beet Sugar Manufacturing Co Ltd
TSE:2108
|
JP |
|
Zhejiang Dafeng Industrial Co Ltd
SSE:603081
|
CN |
|
Shreyas Shipping and Logistics Ltd
NSE:SHREYAS
|
IN |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
436.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 119.9m USD. This includes both short-term (0 USD) and long-term (119.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
